The Effect of JAK Inhibitor Tofacitinib on Chondrocyte Autophagy

Ping Zhang1, Juan Xiao1, Chenggen Luo1

  • 1Department of Rheumatology and Immunology, Affiliated Hospital of Zunyi Medical University, Huichuan District, 149 Dalian Road, Zunyi, 563003, China.

Inflammation
|June 13, 2023
PubMed

Insights

Tofacitinib, a JAK inhibitor, shows promise in treating osteoarthritis (OA) by reducing inflammation and restoring cartilage health. It protects cartilage extracellular matrix and enhances chondrocyte autophagy in OA models.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Osteoarthritis (OA) is a degenerative joint disease with no current cure.
  • The pathogenesis of OA involves complex inflammatory and matrix degradation processes.
  • Janus kinase (JAK) inhibitors, like tofacitinib, possess anti-inflammatory properties.

Purpose of the Study:

  • To investigate tofacitinib's effect on cartilage extracellular matrix in OA.
  • To determine if tofacitinib protects chondrocytes by inhibiting JAK1/STAT3 signaling and upregulating autophagy.
  • To evaluate tofacitinib's therapeutic potential in experimental OA models.

Main Methods:

  • In vitro OA model using SW1353 cells stimulated with interleukin-1β (IL-1β).
  • In vivo OA model induced by the modified Hulth method in rats.
  • Analysis of matrix metalloproteinases (MMPs), collagen II, autophagy markers (beclin1, LC3-II/I, p62), and JAK1/STAT3 pathway activation.

Main Results:

  • IL-1β induced OA-like changes in vitro, increasing MMPs and decreasing collagen II and autophagy markers.
  • Tofacitinib treatment attenuated IL-1β-induced matrix degradation and restored autophagy in vitro.
  • Tofacitinib inhibited the JAK1/STAT3 pathway activation and nuclear translocation of p-STAT3.
  • In vivo, tofacitinib reduced cartilage degeneration and enhanced chondrocyte autophagy in a rat OA model.

Conclusions:

  • Chondrocyte autophagy is impaired in experimental OA models.
  • Tofacitinib demonstrates a protective effect against cartilage degeneration in OA.
  • Tofacitinib reduces inflammation and restores autophagic flux in OA by inhibiting the JAK1/STAT3 pathway.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K